Lifestance Health Group, INC Form 4 insider transactions

LifeStance Health Group, Inc. Executive Vice President Lisa K. Miller reported the withholding of 10,623 shares of common stock to cover tax obligations related to vested Restricted Stock Units.

LifeStance Health Group's Chief People Officer, Ann Varanakis, filed an amended Form 4 to correct previously reported share withholdings for tax obligations related to vested equity awards.

LifeStance Health Group Director Sarah Personette reported the acquisition of 74,766 restricted stock units, representing a future right to common stock.

LifeStance Health Group's Chief People Officer, Ann Varanakis, had 5,233 shares withheld for tax obligations related to vested restricted stock units.

Silversmith Partners, a significant shareholder in LifeStance Health Group, Inc., has filed a Form 4 indicating a planned sale of over 3.5 million shares of common stock in August 2025.

Darren M. Black, a Director and 10% owner of LifeStance Health Group, Inc., reported the sale of over 8.4 million shares of common stock for approximately $42.6 million.

Summit Partners, a 10% owner and director of LifeStance Health Group, Inc., sold over 8.4 million shares of common stock for approximately $42.6 million, reducing its beneficial ownership to 33.5 million shares.

A LifeStance Health Group director acquired over 114,000 shares of common stock in early August 2025, totaling approximately $490,000.

LifeStance Health Group's Chief Medical Officer, Ujjwal Ramtekkar, has filed a Form 4 indicating a planned future sale of 9,519 shares of common stock at a price of $5.17 per share, effective June 16, 2025.

LifeStance Health Group, Inc. Chief Technology Officer Vukasin Paunovich was granted 178,571 restricted stock units, aligning his interests with shareholder value.

LifeStance Health Group, Inc. Director Eric Shuey has reported the acquisition of 35,714 restricted stock units (RSUs) as part of a pre-arranged equity compensation plan.

LifeStance Health Group, Inc. Director Robert Bessler filed a Form 4 detailing the acquisition of 35,714 restricted stock units scheduled for June 11, 2025, alongside his current direct and indirect beneficial ownership.

LifeStance Health Group, Inc. Director Teresa DeLuca has increased her beneficial ownership by acquiring 35,714 shares of common stock through a restricted stock unit grant.

LifeStance Health Group, Inc. Director Eric P. Palmer was granted 71,428 restricted stock units (RSUs) on June 11, 2025, as reported in a recent SEC Form 4 filing.

LifeStance Health Group's Chief Medical Officer, Ujjwal Ramtekkar, reported the sale of 16,000 shares of common stock for approximately $5.94 per share, executed under a pre-arranged trading plan.

Ryan Pardo, Chief Legal Officer and Secretary of LifeStance Health Group, reports disposition of shares to cover tax obligations and beneficial ownership of shares held in trust.

Director Kenneth Burdick reports the withholding of shares by LifeStance Health Group to cover tax obligations related to vested RSUs.

CEO David Bourdon reports transaction related to tax withholding obligations upon vesting of RSUs.

Lisa K. Miller, an executive at LifeStance Health Group, reported a transaction involving the withholding of shares to cover tax obligations upon the vesting of Restricted Stock Units (RSUs).

Pablo Pantaleoni, Chief Digital Officer of LifeStance Health Group, reports the withholding of shares to cover tax obligations related to vested RSUs.

Ann Varanakis, Chief People Officer of LifeStance Health Group, sold shares to cover tax obligations related to vested RSUs.

Ujjwal Ramtekkar, Chief Medical Officer of LifeStance Health Group, reports a transaction involving the withholding of shares to cover tax obligations upon the vesting of Restricted Stock Units (RSUs).

Robert Bessler, a director of LifeStance Health Group, reported the sale of common stock through indirect holdings, as detailed in a recent SEC Form 4 filing.

Ryan Pardo, Chief Legal Officer and Secretary of LifeStance Health Group, reports the withholding of shares to cover tax obligations related to vested restricted stock units.

Pablo Pantaleoni, Chief Digital Officer of LifeStance Health Group, reports the withholding of shares to cover tax obligations upon the vesting of restricted stock units.

Ryan McGroarty, Chief Financial Officer and Treasurer of LifeStance Health Group, acquired 184,911 shares of common stock through restricted stock units on March 24, 2025.

Ryan McGroarty, CFO of LifeStance Health Group, received 362,844 restricted stock units (RSUs) on March 17, 2025, according to an amended SEC Form 4/A filing.

Ryan McGroarty, CFO of LifeStance Health Group, was granted stock options on March 17, 2025, including both time-vesting and performance-vesting options.

Lisa K. Miller, an executive at LifeStance Health Group, sold 18,845 shares of common stock at an average price of $6.90 on March 17, 2025.

Pablo Pantaleoni, Chief Digital Officer of LifeStance Health Group, reports changes in beneficial ownership of company stock due to RSU and PSU vesting and tax withholding.